These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25027548)

  • 1. Novel transgenic rice-based vaccines.
    Azegami T; Itoh H; Kiyono H; Yuki Y
    Arch Immunol Ther Exp (Warsz); 2015 Apr; 63(2):87-99. PubMed ID: 25027548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MucoRice-cholera toxin B-subunit, a rice-based oral cholera vaccine, down-regulates the expression of α-amylase/trypsin inhibitor-like protein family as major rice allergens.
    Kurokawa S; Nakamura R; Mejima M; Kozuka-Hata H; Kuroda M; Takeyama N; Oyama M; Satoh S; Kiyono H; Masumura T; Teshima R; Yuki Y
    J Proteome Res; 2013 Jul; 12(7):3372-82. PubMed ID: 23763241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of toxin-specific neutralizing immunity by molecularly uniform rice-based oral cholera toxin B subunit vaccine without plant-associated sugar modification.
    Yuki Y; Mejima M; Kurokawa S; Hiroiwa T; Takahashi Y; Tokuhara D; Nochi T; Katakai Y; Kuroda M; Takeyama N; Kashima K; Abe M; Chen Y; Nakanishi U; Masumura T; Takeuchi Y; Kozuka-Hata H; Shibata H; Oyama M; Tanaka K; Kiyono H
    Plant Biotechnol J; 2013 Sep; 11(7):799-808. PubMed ID: 23601492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good manufacturing practices production of a purification-free oral cholera vaccine expressed in transgenic rice plants.
    Kashima K; Yuki Y; Mejima M; Kurokawa S; Suzuki Y; Minakawa S; Takeyama N; Fukuyama Y; Azegami T; Tanimoto T; Kuroda M; Tamura M; Gomi Y; Kiyono H
    Plant Cell Rep; 2016 Mar; 35(3):667-79. PubMed ID: 26661780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity.
    Yuki Y; Tokuhara D; Nochi T; Yasuda H; Mejima M; Kurokawa S; Takahashi Y; Kataoka N; Nakanishi U; Hagiwara Y; Fujihashi K; Takaiwa F; Kiyono H
    Vaccine; 2009 Oct; 27(43):5982-8. PubMed ID: 19665603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MucoRice: development of rice-based oral vaccine].
    Yuki Y; Kiyono H
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):369-74. PubMed ID: 18974620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
    Nochi T; Yuki Y; Katakai Y; Shibata H; Tokuhara D; Mejima M; Kurokawa S; Takahashi Y; Nakanishi U; Ono F; Mimuro H; Sasakawa C; Takaiwa F; Terao K; Kiyono H
    J Immunol; 2009 Nov; 183(10):6538-44. PubMed ID: 19880451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative whole-genome analyses of selection marker-free rice-based cholera toxin B-subunit vaccine lines and wild-type lines.
    Kashima K; Mejima M; Kurokawa S; Kuroda M; Kiyono H; Yuki Y
    BMC Genomics; 2015 Feb; 16(1):48. PubMed ID: 25653106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seed Metabolome Analysis of a Transgenic Rice Line Expressing Cholera Toxin B-subunit.
    Ogawa T; Kashima K; Yuki Y; Mejima M; Kurokawa S; Kuroda M; Okazawa A; Kiyono H; Ohta D
    Sci Rep; 2017 Jul; 7(1):5196. PubMed ID: 28701756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of oral immunotherapy with a rice-based edible vaccine containing hypoallergenic Japanese cedar pollen allergens for treatment of established allergic conjunctivitis in mice.
    Fukuda K; Ishida W; Harada Y; Wakasa Y; Takagi H; Takaiwa F; Fukushima A
    Allergol Int; 2018 Jan; 67(1):119-123. PubMed ID: 28676431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative whole-genome and proteomics analyses of the next seed bank and the original master seed bank of MucoRice-CTB 51A line, a rice-based oral cholera vaccine.
    Sasou A; Yuki Y; Honma A; Sugiura K; Kashima K; Kozuka-Hata H; Nojima M; Oyama M; Kurokawa S; Maruyama S; Kuroda M; Tanoue S; Takamatsu N; Fujihashi K; Goto E; Kiyono H
    BMC Genomics; 2021 Jan; 22(1):59. PubMed ID: 33468052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination.
    Nochi T; Takagi H; Yuki Y; Yang L; Masumura T; Mejima M; Nakanishi U; Matsumura A; Uozumi A; Hiroi T; Morita S; Tanaka K; Takaiwa F; Kiyono H
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):10986-91. PubMed ID: 17573530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of allergic conjunctivitis in mice by a rice-based edible vaccine containing modified Japanese cedar pollen allergens.
    Fukuda K; Ishida W; Harada Y; Wakasa Y; Takagi H; Takaiwa F; Fukushima A
    Br J Ophthalmol; 2015 May; 99(5):705-9. PubMed ID: 25563761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi-mediated suppression of endogenous storage proteins leads to a change in localization of overexpressed cholera toxin B-subunit and the allergen protein RAG2 in rice seeds.
    Kurokawa S; Kuroda M; Mejima M; Nakamura R; Takahashi Y; Sagara H; Takeyama N; Satoh S; Kiyono H; Teshima R; Masumura T; Yuki Y
    Plant Cell Rep; 2014 Jan; 33(1):75-87. PubMed ID: 24085308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNAi suppression of rice endogenous storage proteins enhances the production of rice-based Botulinum neutrotoxin type A vaccine.
    Yuki Y; Mejima M; Kurokawa S; Hiroiwa T; Kong IG; Kuroda M; Takahashi Y; Nochi T; Tokuhara D; Kohda T; Kozaki S; Kiyono H
    Vaccine; 2012 Jun; 30(28):4160-6. PubMed ID: 22554467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of Ascaris suum As14 protein and its fusion protein with cholera toxin B subunit in rice seeds.
    Nozoye T; Takaiwa F; Tsuji N; Yamakawa T; Arakawa T; Hayashi Y; Matsumoto Y
    J Vet Med Sci; 2009 Jul; 71(7):995-1000. PubMed ID: 19652493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal immunization using recombinant plant-based oral vaccines.
    Streatfield SJ
    Methods; 2006 Feb; 38(2):150-7. PubMed ID: 16431131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems.
    Harakuni T; Sugawa H; Komesu A; Tadano M; Arakawa T
    Infect Immun; 2005 Sep; 73(9):5654-65. PubMed ID: 16113283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.
    Holmgren J; Adamsson J; Anjuère F; Clemens J; Czerkinsky C; Eriksson K; Flach CF; George-Chandy A; Harandi AM; Lebens M; Lehner T; Lindblad M; Nygren E; Raghavan S; Sanchez J; Stanford M; Sun JB; Svennerholm AM; Tengvall S
    Immunol Lett; 2005 Mar; 97(2):181-8. PubMed ID: 15752556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rice seed for delivery of vaccines to gut mucosal immune tissues.
    Takaiwa F; Wakasa Y; Takagi H; Hiroi T
    Plant Biotechnol J; 2015 Oct; 13(8):1041-55. PubMed ID: 26100952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.